Journal article

The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome

BB Zeev, A Bebbington, G Ho, H Leonard, N De Klerk, E Gak, M Vecksler, J Christodoulou

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2009

Abstract

BACKGROUND:: Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2). Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor playing a major role in neuronal survival, neurogenesis, and plasticity, and it has been shown that BDNF expression is regulated by MeCP2 through a complex interaction. A common polymorphism of BDNF (Val66Met [p.V66M]) has been found to correlate with severity and course of several neuropsychiatric disorders. METHODS:: We examined the association between disease severity score, assessed by the modified Percy score, and BDNF polymorphism, using regression methods, in 125 mutation-positive patients with ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institute of Child Health and Human Development


Funding Acknowledgements

Supported by the NIH (5R01HD043100-05) (major aspects of the Australian Rett Syndrome program) and National Medical and Health Research Council (NHMRC) project grant 303189 (certain clinical aspects). The international Rett Syndrome Research Program through which the Israeli data were accessed is funded by the International Rett Syndrome Foundation. H.L. is funded by a NHMRC program grant (353514) and J.C. is funded by NHMRC project grants (346603 and 457238) and the Rett Syndrome Australian Research Fund.